Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215767) titled 'Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice' on Oct. 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: HALEON
Condition:
Dentin Hypersensitivity
Intervention:
Drug: Stannous fluoride and Potassium nitrate Dentifrice
Drug: Stannous fluoride Dentifrice
Drug: Potassium nitrate Dentifrice
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: September 16, 2025
Target Sample Size: 850
Countries of Recr...